The company’s consolidated net profit for the quarter is likely to drop 10% year-on-year (YoY) to Rs 16,170 crore, according to the average of estimates given by 10 brokerages. Consolidated revenue is seen down 2% YoY at Rs 2.15 lakh crore.
BPCL, Sun Pharma among 7 Nifty50 stocks that hit 52-week highs on Friday
Sensex and Nifty fell into the red on Friday, ending their seven-day winning streak, despite gains in some financial stocks.